Dr. Imran A. Idrees

Bruce L. Jacobs, MD, is an associate professor of urology at the University of Pittsburgh School of Medicine. He received a medical degree from the Vanderbilt University School of Medicine in Nashville, Tenn., and earned a master’s degree in public health from the University of Michigan School of Public Health. Dr. Jacobs completed residencies in general surgery and urology at the University of Pittsburgh, and fellowships in health services research, laparoscopy/endourology, and urologic oncology at the University of Michigan. Dr. Jacobs is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.

Aiman Daghestani, MD, specializes in medical oncology and is certified by the American Board of Internal Medicine. He is affiliated with UPMC Somerset and UPMC Altoona. He completed his medical degree at Aleppo University School of Medicine, residencies at MedStar Franklin Square Medical Center and Mercy Hospital and Medical Center, and fellowship at Memorial Sloan-Kettering Cancer Center. Dr. Daghestani is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Paget Disease of the Breast, Muscle Invasive Bladder Cancer, Urothelial Cancer, and Familial Pancreatic Cancer.

Tatum V. Tarin, MD, is an Associate Professor of Urology at the University of Pittsburgh School of Medicine. He earned his medical degree from the University of Pittsburgh, and completed residencies in surgery and urology at Stanford University Medical Center. He also completed a fellowship in urological oncology at Memorial Sloan-Kettering Cancer Center in New York, N.Y., where he was a clinical instructor for two years prior to joining UPMC. Dr. Tarin is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Lymphadenectomy, and Nephrectomy.